Antibody & Monoclonal Therapeutics

Therapeutic antibodies and monoclonal antibody technologies play a pivotal role in preventing and treating a wide range of diseases, including cancer, infectious diseases, and autoimmune disorders. Research focuses on antibody design, engineering, and optimization to enhance specificity, efficacy, and safety. Novel approaches include bispecific antibodies, antibody-drug conjugates, and humanized monoclonal antibodies. These therapies can neutralize pathogens, modulate immune responses, or target disease-specific cells. Advances in antibody therapeutics continue to expand personalized medicine, offering precise, effective, and adaptable treatment options for diverse clinical challenges.

    Related Conference of Antibody & Monoclonal Therapeutics

    November 16-17, 2026

    11th Global Summit on Midwifery and Womens Health

    Tokyo, Japan
    December 16-17, 2026

    7th Global Summit on Public Health

    Amsterdam, Netherlands
    January 18-19, 2027

    44th International Conference on Womens Health

    Bangkok, Thailand
    January 18-19, 2027

    10th World Congress on PCOS and Reproductive Healthcare

    Bangkok, Thailand
    February 01-02, 2027

    9th International Conference on Digital Health

    London, UK
    February 15-16, 2027

    23rd World Congress on Healthcare & Technologies

    Paris, France
    May 17-18, 2027

    38th European Heart and Heart Failure Congress

    Paris, France
    July 26-27, 2027

    5th Global Conference on Aging and Gerontology

    Paris, France
    August 24-25, 2027

    23rd Global Biomarkers and Clinical Research Summit

    Paris, France

    Antibody & Monoclonal Therapeutics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in